Announcements Trials

Browse Landscape

Phase

Phase 1 6 Phase 2 5 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Head & Neck 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1

Conditions

Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 21 fludarabine 12 Rituximab 10 Vincristine 6 Etoposide 6 Prednisone 5 Doxorubicin 5 pembrolizumab 4 Radiotherapy 4 Methotrexate 4 Magnetic Resonance Spectroscopy 4 Immunotherapy, Adoptive 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Dexamethasone 4 venetoclax 3 ibrutinib 3 Nivolumab 3 Imiquimod 3 Ifosfamide 3 Exercise 3 Biopsy 3 68Ga-pentixafor 3 fludarabine phosphate 2 daratumumab 2 Transplantation 2 Stem Cell Transplantation 2 Specimen Handling 2 Sirolimus 2 Roflumilast 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × avelumab × Lymphoid × Clear all

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡